Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, presenting promising advancements across a variety of clinical and industrial programs. With its structural similarity to The natural way derived human serum albumin, OsrHSA provides a safer, additional dependable alternative for the